Unforeseen consequences: Class III antiarrhythmic amiodarone stimulated increase in prostate-specific antigen.

Authors

• Philip C Wiener
• Savalan Babapoor-Farrokhran
• Travis Reinaker
• Sumeet K Mainigi

Publication/Presentation Date

5-1-2021

Volume

7

Issue

5

First Page

267

Last Page

269

ISSN

2214-0271

Published In/Presented At

Wiener, P. C., Babapoor-Farrokhran, S., Reinaker, T., & Mainigi, S. K. (2021). Unforeseen consequences: Class III antiarrhythmic amiodarone stimulated increase in prostate-specific antigen. HeartRhythm case reports, 7(5), 267–269. https://doi.org/10.1016/j.hrcr.2021.01.015

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

34026512

Department(s)

Administration and Leadership

Document Type

Article